Cover Image
市場調查報告書

DaVinci Biosciences, LLC:產品平台分析

DaVinci Biosciences, LLC - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 321942
出版日期 內容資訊 英文 18 Pages
訂單完成後即時交付
價格
Back to Top
DaVinci Biosciences, LLC:產品平台分析 DaVinci Biosciences, LLC - Product Pipeline Review - 2015
出版日期: 2015年05月13日 內容資訊: 英文 18 Pages
簡介

DaVinci Biosciences, LLC是正在開發治療退化性疾病之生物製藥的生物科技企業,開發基於細胞之治療藥,以提供治療脊髓損傷,心血管疾病,神經疾病,關節炎,由於運動造成的傷害,自體免疫疾病等患者。

本報告提供DaVinci Biosciences, LLC 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,同時也提供最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

DaVinci Biosciences, LLC的基本資料

DaVinci Biosciences, LLC概要

  • 主要資訊
  • 企業資料

DaVinci Biosciences, LLC: R&D 概要

  • 主要的治療範圍

DaVinci Biosciences, LLC:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

DaVinci Biosciences, LLC:開發中產品概況

  • 初期階段的開發中產品
    • 藥物研發中的產品/聯合治療模式

DaVinci Biosciences, LLC:藥物簡介

  • Stem Cell Therapy for Autoimmune Diseases
  • Stem Cell Therapy for Cardiovascular Diseases
  • Stem Cell Therapy for Neurological Diseases

DaVinci Biosciences, LLC:開發平台分析

  • 各分子類型

DaVinci Biosciences, LLC:暫停中的計劃

DaVinci Biosciences, LLC:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07089CDB

Summary

Global Markets Direct's, 'DaVinci Biosciences, LLC - Product Pipeline Review - 2015', provides an overview of the DaVinci Biosciences, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of DaVinci Biosciences, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of DaVinci Biosciences, LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of DaVinci Biosciences, LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the DaVinci Biosciences, LLC's pipeline products

Reasons to buy

  • Evaluate DaVinci Biosciences, LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of DaVinci Biosciences, LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the DaVinci Biosciences, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of DaVinci Biosciences, LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of DaVinci Biosciences, LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of DaVinci Biosciences, LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • DaVinci Biosciences, LLC Snapshot
    • DaVinci Biosciences, LLC Overview
    • Key Information
    • Key Facts
  • DaVinci Biosciences, LLC - Research and Development Overview
    • Key Therapeutic Areas
  • DaVinci Biosciences, LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • DaVinci Biosciences, LLC - Pipeline Products Glance
    • DaVinci Biosciences, LLC - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • DaVinci Biosciences, LLC - Drug Profiles
    • Stem Cell Therapy for Arthritis and Sports Injuries
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Stem Cell Therapy for Autoimmune Diseases
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Stem Cell Therapy for Cardiovascular Diseases
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Stem Cell Therapy for Neurological Diseases
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • DaVinci Biosciences, LLC - Pipeline Analysis
  • DaVinci Biosciences, LLC - Pipeline Products by Molecule Type
  • DaVinci Biosciences, LLC - Dormant Projects
  • DaVinci Biosciences, LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • DaVinci Biosciences, LLC, Key Information
  • DaVinci Biosciences, LLC, Key Facts
  • DaVinci Biosciences, LLC - Pipeline by Indication, 2015
  • DaVinci Biosciences, LLC - Pipeline by Stage of Development, 2015
  • DaVinci Biosciences, LLC - Monotherapy Products in Pipeline, 2015
  • DaVinci Biosciences, LLC - Discovery, 2015
  • DaVinci Biosciences, LLC - Pipeline by Molecule Type, 2015
  • DaVinci Biosciences, LLC - Dormant Developmental Projects,2015

List of Figures

  • DaVinci Biosciences, LLC - Pipeline by Top 10 Indication, 2015
Back to Top